BG107678A - Тиазолидиндионово производно и използването му като антидиабетично средство - Google Patents

Тиазолидиндионово производно и използването му като антидиабетично средство Download PDF

Info

Publication number
BG107678A
BG107678A BG107678A BG10767803A BG107678A BG 107678 A BG107678 A BG 107678A BG 107678 A BG107678 A BG 107678A BG 10767803 A BG10767803 A BG 10767803A BG 107678 A BG107678 A BG 107678A
Authority
BG
Bulgaria
Prior art keywords
potassium salt
pharmaceutically acceptable
thiazolidine
ethoxy
benzyl
Prior art date
Application number
BG107678A
Other languages
Bulgarian (bg)
English (en)
Inventor
Michael Millan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9900427&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG107678(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG107678A publication Critical patent/BG107678A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG107678A 2000-09-29 2003-03-26 Тиазолидиндионово производно и използването му като антидиабетично средство BG107678A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0023970.7A GB0023970D0 (en) 2000-09-29 2000-09-29 Novel pharmaceutical
PCT/GB2001/004346 WO2002026736A1 (en) 2000-09-29 2001-09-28 A thiazolidinedione derivative and its use as antidiabetic

Publications (1)

Publication Number Publication Date
BG107678A true BG107678A (bg) 2003-11-28

Family

ID=9900427

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107678A BG107678A (bg) 2000-09-29 2003-03-26 Тиазолидиндионово производно и използването му като антидиабетично средство

Country Status (34)

Country Link
US (1) US20040038968A1 (zh)
EP (2) EP1795531A1 (zh)
JP (1) JP2004509960A (zh)
KR (2) KR100822135B1 (zh)
CN (2) CN101961333A (zh)
AP (1) AP1841A (zh)
AT (1) ATE368038T1 (zh)
AU (2) AU9203401A (zh)
BG (1) BG107678A (zh)
BR (1) BR0114364A (zh)
CA (1) CA2423978A1 (zh)
CY (1) CY1107767T1 (zh)
CZ (1) CZ2003849A3 (zh)
DE (1) DE60129576T2 (zh)
DK (1) DK1325000T3 (zh)
DZ (1) DZ3481A1 (zh)
EA (1) EA005110B1 (zh)
EC (1) ECSP034529A (zh)
ES (1) ES2290169T3 (zh)
GB (1) GB0023970D0 (zh)
HK (1) HK1058192A1 (zh)
HU (1) HUP0301199A3 (zh)
IL (2) IL155140A0 (zh)
MA (1) MA25913A1 (zh)
MX (1) MXPA03002867A (zh)
NO (2) NO324970B1 (zh)
NZ (1) NZ524932A (zh)
OA (1) OA12400A (zh)
PL (1) PL361157A1 (zh)
PT (1) PT1325000E (zh)
SK (1) SK3792003A3 (zh)
UA (1) UA76121C2 (zh)
WO (1) WO2002026736A1 (zh)
ZA (1) ZA200302438B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates
HUP0800755A2 (en) 2008-12-11 2010-09-28 Richter Gedeon Nyrt Crystalline forms of rosiglitazone

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646169A (en) * 1987-09-04 1997-07-08 Beecham Group P.L.C. Compounds for treating eating disorders in which blood glucose levels are raised
DE10199003I1 (de) * 1987-09-04 2003-06-12 Beecham Group Plc Substituierte Thiazolidinionderivate
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
GB9712866D0 (en) * 1997-06-18 1997-08-20 Smithkline Beecham Plc Novel method of treatment
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates

Also Published As

Publication number Publication date
DK1325000T3 (da) 2007-11-12
HUP0301199A2 (hu) 2003-11-28
PT1325000E (pt) 2007-10-25
IL155140A0 (en) 2003-10-31
AU2001292034B2 (en) 2005-04-21
CZ2003849A3 (cs) 2004-03-17
DZ3481A1 (fr) 2002-04-04
EP1795531A1 (en) 2007-06-13
BR0114364A (pt) 2003-12-09
ES2290169T3 (es) 2008-02-16
KR20070089258A (ko) 2007-08-30
WO2002026736A1 (en) 2002-04-04
IL155140A (en) 2010-06-30
MA25913A1 (fr) 2003-10-01
AP2003002766A0 (en) 2003-03-31
NO20075507L (no) 2003-05-27
HK1058192A1 (en) 2004-05-07
AP1841A (en) 2008-04-30
NZ524932A (en) 2005-06-24
US20040038968A1 (en) 2004-02-26
SK3792003A3 (en) 2004-04-06
DE60129576D1 (de) 2007-09-06
ECSP034529A (es) 2003-05-26
EP1325000B1 (en) 2007-07-25
EA005110B1 (ru) 2004-10-28
NO20031434D0 (no) 2003-03-28
DE60129576T2 (de) 2008-04-17
KR100822135B1 (ko) 2008-04-15
OA12400A (en) 2004-09-06
ZA200302438B (en) 2004-04-28
NO324970B1 (no) 2008-01-14
CN1620453A (zh) 2005-05-25
UA76121C2 (en) 2006-07-17
PL361157A1 (en) 2004-09-20
CN1620453B (zh) 2010-12-08
GB0023970D0 (en) 2000-11-15
JP2004509960A (ja) 2004-04-02
HUP0301199A3 (en) 2005-04-28
EA200300423A1 (ru) 2003-08-28
EP1325000A1 (en) 2003-07-09
KR20030032058A (ko) 2003-04-23
CY1107767T1 (el) 2013-04-18
MXPA03002867A (es) 2004-12-06
NO20031434L (no) 2003-05-27
CN101961333A (zh) 2011-02-02
ATE368038T1 (de) 2007-08-15
CA2423978A1 (en) 2002-04-04
AU9203401A (en) 2002-04-08

Similar Documents

Publication Publication Date Title
EP1305312B1 (en) Tartrate salts of thiazolidinedione derivative
BG107607A (bg) Хидрохлоридна сол на 5-[4-[2-(n-метил-n-(2-пиридил)амино)етокси]бензил]тиазолидин-2,4-дион
BG107678A (bg) Тиазолидиндионово производно и използването му като антидиабетично средство
BG107605A (bg) Тартаратни соли на тиазолидиндионово производно
BG107679A (bg) Натриеви соли на 5-[4-[2-(n-метил-n-(2-пиридил)амино)етокси]бензил]тиазолидин-2,4-дион
EP1305310B1 (en) Tartrate salts of thiazolidinedione derivative
EA005408B1 (ru) Тартратная соль производного тиазолидиндиона
BG107356A (bg) 5-(4-(2-(n-метил-n-(2-пиридил)амино)етокси)бензил)тиазолидин-2,4-дион хидройодид като фармацевтиченсъстав
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative
AU2001292034A1 (en) A thiazolidinedione derivative and its use as antidiabetic
WO2003050112A1 (en) Toluenesulfonate hydrates of a thiazolidinedione derivative